Nwam LLC Purchases Shares of 1,775 The Clorox Company (NYSE:CLX)

Nwam LLC acquired a new position in shares of The Clorox Company (NYSE:CLX) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,775 shares of the company’s stock, valued at approximately $289,000.

Other large investors also recently made changes to their positions in the company. Mizuho Securities USA LLC lifted its holdings in shares of Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after purchasing an additional 4,490,421 shares in the last quarter. Van ECK Associates Corp lifted its stake in shares of Clorox by 1,715.5% in the second quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock valued at $199,411,000 after buying an additional 1,380,724 shares in the last quarter. Nuance Investments LLC grew its holdings in shares of Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after buying an additional 960,094 shares during the last quarter. Wulff Hansen & CO. increased its position in shares of Clorox by 13,547.0% during the second quarter. Wulff Hansen & CO. now owns 440,116 shares of the company’s stock worth $60,063,000 after acquiring an additional 436,891 shares in the last quarter. Finally, International Assets Investment Management LLC raised its holdings in shares of Clorox by 424.9% in the 3rd quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock worth $877,390,000 after acquiring an additional 435,971 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.57% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

CLX has been the subject of a number of recent research reports. Evercore ISI decreased their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and increased their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Barclays lifted their price objective on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. Finally, Citigroup boosted their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Five investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $155.00.

Clorox Price Performance

Shares of NYSE CLX opened at $166.32 on Tuesday. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The stock has a fifty day simple moving average of $162.79 and a two-hundred day simple moving average of $148.71. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.35. The firm has a market cap of $20.59 billion, a price-to-earnings ratio of 57.95, a price-to-earnings-growth ratio of 3.13 and a beta of 0.41.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the company earned $0.49 EPS. The firm’s quarterly revenue was up 27.0% compared to the same quarter last year. Analysts anticipate that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 2.93%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is currently 170.04%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.